EP Patent

EP2575778A1 — Pharmaceutical compositions of co-crystals of tramadol and coxibs

Assigned to Esteve Pharmaceuticals SA · Expires 2013-04-10 · 13y expired

What this patent protects

The present invention relates to oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib, processes for preparation of the same and their use as medicaments, more particularly for the treatment of pain.

USPTO Abstract

The present invention relates to oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib, processes for preparation of the same and their use as medicaments, more particularly for the treatment of pain.

Drugs covered by this patent

Patent Metadata

Patent number
EP2575778A1
Jurisdiction
EP
Classification
—
Expires
2013-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Esteve Pharmaceuticals SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.